Emergex Vaccines Holding Limited (Emergex), a biotechnology company pioneering a new approach to synthetic vaccine devel...
Medical Technology company IME Medical Electrospinning, developer, producer and scientific partner in the field of biome...
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...
Neurimmune has announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceut...
Singapore - A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify ...
Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist support and a...
A team of researchers from the University of British Columbia, Canada has isolated an enzyme in the gut that reliably co...
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...
The National Institutes of Health (NIH) has announced the launch of a new initiative to help speed the development of cu...
State Corporation Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have s...
Health services organization Cigna has launched Cigna Ventures, a corporate venture fund with an infusion of $250 millio...
Singapore – Fullerton Healthcare Corporation announced that its wholly owned subsidiaries, Fullerton Health P...
Systech, a global technology leader in brand protection and product authentication, and FarmaTrust, a leader in pharmace...
A group of scientists at the University of Manchester, UK has developed the first non-antibiotic drug to successfully tr...
Genesys Spine is pleased to announce the FDA clearance of our latest product line, the AIS-C Stand-Alone System. The AI...
Singapore - BloodCenter of Wisconsin, part of Versiti, is among four academic and research centers which will recei...
Singapore - The UK's National Institute for Health and Care Excellence rejected Roche's OCREVUS (ocrelizumab) for p...
Singapore - Medivir AB announced it has appointed Linda Basse as Chief Medical Officer effective October ...
